Description
Each vial contains a highly pure combination of Cagrilintide and Semaglutide (CagriSema). CagriSema pairs a long-acting amylin analog with a GLP-1 receptor agonist and is investigated in metabolic research for synergistic effects on appetite regulation, glycemic control, and weight reduction.






Reviews
There are no reviews yet.